Bristol-Myers Squibb Company
BMY
$56.45
$0.781.40%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.00% | 1,409.72% | 81.75% | -22.02% | 120.62% |
| Total Depreciation and Amortization | -39.68% | -44.62% | -60.29% | -61.69% | -59.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 82.58% | 22.14% | -82.76% | 269.98% | -97.05% |
| Change in Net Operating Assets | -51.47% | -229.62% | 78.97% | 100.63% | -1,044.95% |
| Cash from Operations | -43.50% | -55.53% | 12.88% | 68.40% | -31.05% |
| Capital Expenditure | -33.46% | 2.12% | 1.23% | -37.79% | 8.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 16.67% | -3,531.91% | -438.51% | 79.24% | 99.61% |
| Divestitures | 28.40% | -16.22% | 9.41% | 0.00% | 0.83% |
| Other Investing Activities | 92.33% | 426.92% | 7.58% | -310.87% | -184.52% |
| Cash from Investing | 73.75% | -643.88% | -677.17% | 64.14% | 97.46% |
| Total Debt Issued | -12.77% | 1,417.04% | -94.74% | -82.21% | -97.69% |
| Total Debt Repaid | -- | -- | 91.66% | 79.43% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.99% | -3.61% | -3.87% | -3.70% | -3.80% |
| Other Financing Activities | 4.85% | -73.68% | -118.75% | 283.33% | -6.19% |
| Cash from Financing | -57.10% | -267.17% | 61.32% | 54.36% | -106.78% |
| Foreign Exchange rate Adjustments | -172.73% | 103.40% | -105.19% | 681.82% | 246.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -220.27% | -324.45% | 95.05% | 157.14% | 124.16% |